AM Best Affirms Credit Ratings of MetLife, Inc. and Most of Its Life/Health Subsidiaries - Seite 2

The ratings also reflect the organization’s strong, defensible market positions in its core lines of business and the diversity of its products and geographic markets in the United States, Asia and Latin America, as well as the Europe, Middle East and Africa region.

The FSR of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) have been affirmed with stable outlooks for the following subsidiaries of MetLife, Inc., collectively referred to as Metropolitan Life Group:

• Delaware American Life Insurance Company
• Metropolitan Life Insurance Company
• Metropolitan Tower Life Insurance Company
• SafeGuard Health Plans, Inc. (TX)
• SafeGuard Health Plans, Inc. (FL)
• SafeGuard Health Plans, Inc. (CA)
• MetLife Global Benefits, Ltd.

The following Short-Term IRs have been affirmed:

MetLife Funding, Inc.—
-- AMB-1+ (Strongest) on commercial paper

MetLife, Inc.—
-- AMB-1 (Outstanding) on commercial paper

The following Long-Term IRs have been affirmed with a stable outlook:

MetLife, Inc.—
-- “a-” (Excellent) on USD 1.0 billion 4.368% senior unsecured debentures, due 2023
-- “a-” (Excellent) on USD 1.0 billion 3.60% senior unsecured notes, due 2024
-- “a-” (Excellent) on GBP 350 million 5.375% senior unsecured notes, due 2024
-- “a-” (Excellent) on USD 500 million 3.60% senior unsecured notes, due 2025
-- “a-” (Excellent) on USD 500 million 3.0% senior unsecured notes, due 2025
-- “a-” (Excellent) on JPY 25.2 billion 0.495% senior unsecured notes, due 2026
-- “a-” (Excellent) on JPY 64.9 billion 0.769% senior unsecured notes, due 2029
-- “a-” (Excellent) on USD 1.0 billion 4.55% senior unsecured notes, due 2030
-- “a-” (Excellent) on JPY 10.7 billion 0.898% senior unsecured notes, due 2031
-- “a-” (Excellent) on USD 600 million 6.50% senior unsecured notes, due 2032
-- “a-” (Excellent) on USD 750 million 6.375% senior unsecured notes, due 2034
-- “a-” (Excellent) on JPY 26.5 billion 1.189% senior unsecured notes, due 2034
-- “a-” (Excellent) on USD 1.0 billion 5.70% senior unsecured notes, due 2035
-- “a-” (Excellent) on JPY 24.4 billion 1.385% senior unsecured notes, due 2039
-- “a-” (Excellent) on USD 750 million 5.875% senior unsecured notes, due 2041
-- “a-” (Excellent) on USD 750 million 4.125% senior unsecured notes, due 2042
-- “a-” (Excellent) on USD 1.0 billion 4.875% senior unsecured notes, due 2043
-- “a-” (Excellent) on USD 500 million 4.721% senior unsecured debentures, due 2044
-- “a-” (Excellent) on USD 1.0 billion 4.05% senior unsecured notes, due 2045
-- “a-” (Excellent) on USD 750 million 4.6% senior unsecured notes, due 2046